Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2021
Novel adjuvant options for cutaneous melanomaF Dimitriou, G V Long, A M MenziesDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 16, 2019
[Histiocytosis in the dermatological context of the new classification]C Lang, J-T Maul, L Krähenbühl, et al.Cancer Medicine|April 29, 2023
Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune checkpoint inhibitorsE L Looman, P F Cheng, J Lai-Kwon, et al.BMC Cancer|April 16, 2020
Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effectJ Boegeholz, C S Brueggen, C Pauli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2021
FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanomaF Dimitriou, S N Lo, A C Tan, et al.The British Journal of Dermatology|June 17, 2021
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivityE Papadavid, E Kapniari, V Pappa, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 20, 2020
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre studyM-C Brüggen, J Valencak, R Stranzenbach, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort studyF Dimitriou, K Namikawa, I L M Reijers, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanomaP Grover, S N Lo, I Li, et al.Pageof 1